Brawn Biotech Limited (BOM:530207)

Brawn Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 27, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	66	63	49	60	50	52
Market Cap Growth	24.29%	28.31%	-18.75%	20.85%	-4.61%	-21.49%
Enterprise Value	63	61	46	56	47	48
Last Close Price	22.00	20.85	16.25	20.00	16.55	17.35

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 27, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	6.75	6.65	-	-	-	-
PS Ratio	0.39	0.37	0.36	0.36	0.22	0.60
PB Ratio	1.52	1.44	1.45	1.19	0.79	0.72
P/TBV Ratio	1.52	1.44	1.45	1.19	0.79	0.72
P/FCF Ratio	77.09	73.06	-	-	22.33	-
P/OCF Ratio	59.01	55.93	102.80	-	15.62	27.72

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 27, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.37	0.36	0.34	0.34	0.21	0.56
EV/FCF Ratio	73.81	70.85	-	-	21.32	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 27, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Debt / Equity Ratio	-0.06	-0.06	-0.06	-0.08	-0.07	-0.03
Net Debt / EBITDA Ratio	0.86	0.86	0.11	0.26	1.48	0.11
Net Debt / FCF Ratio	-3.28	-3.28	1.03	10.54	-1.97	2.06
Asset Turnover	0.82	0.82	0.77	1.13	1.57	0.62
Inventory Turnover	1.42	1.42	1.47	2.69	4.06	2.77
Quick Ratio	0.25	0.25	0.39	0.67	0.73	0.63
Current Ratio	1.13	1.13	1.88	2.02	1.67	1.93
Return on Equity (ROE)	24.43%	24.43%	-41.30%	-21.93%	-12.83%	-20.54%
Return on Assets (ROA)	-1.36%	-1.36%	-6.69%	-6.71%	-1.79%	-9.30%
Return on Invested Capital (ROIC)	-11.84%	-12.42%	-47.91%	-29.67%	-6.30%	-26.72%
Return on Capital Employed (ROCE)	-7.90%	-7.90%	-16.80%	-19.30%	-6.30%	-27.60%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 27, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	14.25%	15.04%	-35.69%	-20.78%	-17.48%	-31.59%
FCF Yield	1.30%	1.37%	-3.98%	-0.63%	4.48%	-2.10%
Buyback Yield / Dilution	3.83%	3.83%	-	-	-	-
Total Shareholder Return	3.83%	3.83%	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error